Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| FluoRok | 2025 | Grant | $2.0M | Oxford |
| Navlive | 2025 | Seed | $4.5M | Oxford |
| Porpoise Power | 2025 | Pre-Seed | $1.6M | Oxford |
| Mode Labs | 2025 | Pre-Seed | $4.0M | Oxford |
| Seloxium | 2025 | Seed | $6.0M | Oxford |
| Alloyed | 2025 | Series B | $48.0M | Yarnton |
| Mixergy | 2025 | Series Unknown | $15.4M | Cassington |
| Neu Health | 2025 | Seed | $2.0M | Oxford |
| Perspectum | 2024 | Grant | $245K | Oxford |
| natcap | 2024 | Series A | $10.0M | London |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | FluoRok | Grant | $2.0M | Oxford, United Kingdom |
| 52 | Navlive | Seed | $4.5M | Oxford, United Kingdom |
| 53 | Porpoise Power | Pre-Seed | $1.6M | Oxford, United Kingdom |
| 54 | Mode Labs | Pre-Seed | $4.0M | Oxford, United Kingdom |
| 55 | Seloxium | Seed | $6.0M | Oxford, United Kingdom |
| 56 | Alloyed | Series B | $48.0M | Yarnton, United Kingdom |
| 57 | Mixergy | Series Unknown | $15.4M | Cassington, United Kingdom |
| 58 | Neu Health | Seed | $2.0M | Oxford, United Kingdom |
| 59 | Perspectum | Grant | $245K | Oxford, United Kingdom |
| 60 | natcap | Series A | $10.0M | London, United Kingdom |
FluoRok is revolutionizing the way fluorochemicals are produced globally.
NavLive creates instant 2D and 3D models, along with accurate site surveys using user-friendly Scan-to-BIM functionality.
Porpoise Power develops bio-inspired tidal energy systems delivering predictable, low-impact renewable power from ocean currents.
Mode Labs provide robust, continuous, and remote real-time chemical sensors.
Seloxium is innovative research that makes it possible to extract necessary metals in an environmentally friendly manner.
Alloyed develops, licenses, and manufactures proprietary alloys, alloy powders and alloy components.
Mixergy offer a cost-effective solution to save energy and facilitate more renewable power generation.
Neu Health enables clinicians, caregivers, and patients to tackle this growing challenge with cutting-edge digital technologies.
Perspectum provides imaging solutions to help doctors in clinical decision-making as well as support patient engagement.
natcap is a nature intelligence company that provides report and act on impacts and dependencies on nature.
PQShield is a post-quantum cryptography company that develops cryptographic algorithms and protocols to secure technology infrastructures.
Amber Therapeutics develops the next-generation of bioelectrical therapies.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms.
A med-tech startup that has developed a passive and contactless device for monitoring nocturnal symptoms and environmental metrics at home.
Oxford Quantum Circuits develops quantum computers designed for breakthrough discoveries.
Proxisense has developed extreme environment proximity sensors and fluid contamination systems.
Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.
Oxford Ionics is a quantum computing startup that provides innovations for the development of accurate and dependable quantum computers.
Building the most advanced global infrastructure for People Science.
Covatic is the use of mobile based algorithms to bring smart personalisation to apps.
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.
QuantrolOx is building automated machine learning-based control software for quantum technologies to tune, stabilize, and optimize qubits.
Quantum Motion is building a universal quantum computer in Silicon, using CMOS compatible processes.
Oxford VR is an evidence-based immersive treatment for serious mental illness and behavioral health.
Oxford Science Enterprises has invested in 100 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Oxford Science Enterprises's top investment sectors include Health Care, Quantum Computing, Biotechnology, Software, Electronics. The firm invests across 55 different industry categories.
Among tracked funding rounds, Amber Therapeutics received $101.8M in a Series A round. Oxford Science Enterprises's total known invested capital is $1.3B.
Oxford Science Enterprises's average investment size is $20.4M across its portfolio of 100 companies.
Recent Oxford Science Enterprises portfolio additions include FluoRok, Navlive, Porpoise Power, Mode Labs, Seloxium. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors